カタログ製品コード : C-EK12142
Human CCL27/CTACK ELISA kit
24T | ¥55,200 | (¥2,300/T) (税別) |
48T | ¥69,200 | (¥1,442/T) (税別) |
96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-EK12142
Human CCL27/CTACK ELISA kit
24T | ¥55,200 | (¥2,300/T) (税別) |
48T | ¥69,200 | (¥1,442/T) (税別) |
96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
MultiSciences | CCL27/CTACK | Human | 93.75 - 6000 pg/ml | 50 μl | 血清、血漿、細胞培養上清 |
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
96-well polystyrene microplate coated with a monoclonal antibody against CCL27 |
Human CCL27 Standard, lyophilized |
CCL27 Detect Antibody |
Standard Diluent |
Streptavidin-HRP |
Assay Buffer (10×) |
Substrate (TMB) |
Stop Solution |
Washing Buffer (20×) |
Plate Covers |
■キーワード :
Homo sapiens,Human,C-C motif chemokine 27,CC chemokine ILC,Cutaneous T-cell-attracting chemokine,CTACK,ESkine,IL-11 R-alpha-locus chemokine,Skinkine,Small-inducible cytokine A27,CCL27,ILC,SCYA27
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human CCL27. The Human CCL27/CTACK ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Chemokine (C-C motif) ligand 27 (CCL27), also known as cutaneous T-cell-attracting chemokine (CTACK), is a small cytokine belonging to the CC chemokine family. Its gene is located on human chromosome 9. CCL27 is expressed in numerous tissues, including gonads, thymus, placenta and skin. In vitro expression can be induced beyond constitutive levels by stimulation with IL-1β or TNF-α, while gluticosteroids can suppress it. CCL27 elicits its chemotactic effects by binding to the chemokine receptor CCR10. It is associated with homing of memory T lymphocytes to the skin, and plays a role in T cell-mediated inflammation of the skin. In healthy mice, lymphocytes accumulate at sites of CCL27 injection. In a mouse contact-hypersensitivity model, lymphocyte recruitment is impaired by administration of anti-CCL27 neutralizing antibodies.